[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100054119":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":38,"locations":47,"responsibleParty":188,"collaborators":190,"id":193,"slug":194,"hasResults":195,"nctId":196,"briefTitle":197,"officialTitle":198,"acronym":199,"eligibilityCriteria":200,"healthyVolunteers":195,"sex":201,"minAge":202,"maxAge":26,"enrollmentInfo":203,"targetDuration":26,"studyType":206,"phases":207,"briefSummary":209,"conditions":210,"keywords":212,"overallStatus":50,"whyStopped":26,"lastUpdateSubmitDate":222,"lastUpdatePostDateStruct":223,"startDateStruct":226,"completionDateStruct":228,"leadSponsor":230,"locationsCount":231},{"fullName":5,"class":6},"University Hospital, Basel, Switzerland","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Linezolid","EXPERIMENTAL","600mg twice a day for 5 days (in addition to the standard antibiotic treatment)",[13],"Drug: Linezolid 600 mg",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","oral placebo tablets twice a day for 5 days (in addition to the standard antibiotic treatment)",[19],"Drug: Placebo",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Linezolid 600 mg","linezolid 600 mg tablets (twice a day for 5 days)",[9],null,{"type":22,"name":15,"description":28,"armGroupLabels":29,"otherNames":26},"Placebo tablets (twice a day for 5 days)",[15],[31,34,36],{"name":32,"affiliation":5,"role":33},"Richard Kühl, PD Dr. med.","PRINCIPAL_INVESTIGATOR",{"name":35,"affiliation":5,"role":33},"Benjamin Speich, PD, PhD",{"name":37,"affiliation":5,"role":33},"Nina Khanna, Prof. Dr. med.",[39,43],{"name":32,"role":40,"phone":41,"phoneExt":26,"email":42},"CONTACT","+41 61 328 66 61","richardalexander.kuehl@usb.ch",{"name":44,"role":40,"phone":45,"phoneExt":26,"email":46},"Natalie Rose, PhD","+41 61 328 35 54","natalie.rose@usb.ch",[48,64,76,88,100,112,124,136,148,159,167,179],{"facility":49,"status":50,"city":51,"state":52,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"Kantonsspital Aarau (KSA)","RECRUITING","Aarau","Canton of Aargau","Switzerland","CH",{"type":56,"coordinates":57},"Point",[58,59],8.04422,47.39254,{"lat":59,"lon":58},[62],{"name":63,"role":33,"phone":26,"phoneExt":26,"email":26},"Anna Conen, PD Dr. med. MSc.",{"facility":65,"status":50,"city":66,"state":67,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"St. Claraspital","Basel","Canton of Basel-City",{"type":56,"coordinates":69},[70,71],7.57327,47.55839,{"lat":71,"lon":70},[74],{"name":75,"role":33,"phone":26,"phoneExt":26,"email":26},"Elisabeth Wehrle-Wieland, Dr. med.",{"facility":77,"status":50,"city":78,"state":79,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"Inselspital Bern","Bern","Canton of Bern",{"type":56,"coordinates":81},[82,83],7.44744,46.94809,{"lat":83,"lon":82},[86],{"name":87,"role":33,"phone":26,"phoneExt":26,"email":26},"Christine Thurnheer, PD Dr. med.",{"facility":89,"status":50,"city":90,"state":91,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":92,"geoPoint":96,"contacts":97},"Hôpitaux universitaires de Genève (HUG)","Geneva","Canton of Geneva",{"type":56,"coordinates":93},[94,95],6.14569,46.20222,{"lat":95,"lon":94},[98],{"name":99,"role":33,"phone":26,"phoneExt":26,"email":26},"Stephan Harbarth, Prof. Dr. med.",{"facility":101,"status":50,"city":102,"state":103,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Hôpital du Jura","Delémont","Canton of Jura",{"type":56,"coordinates":105},[106,107],7.34453,47.36493,{"lat":107,"lon":106},[110],{"name":111,"role":33,"phone":26,"phoneExt":26,"email":26},"Michèle Birrer, Dre",{"facility":113,"status":50,"city":114,"state":115,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":116,"geoPoint":120,"contacts":121},"HOCH Health Ostschweiz, Kantonsspital St.Gallen","Sankt Gallen","Canton of St. Gallen",{"type":56,"coordinates":117},[118,119],9.37477,47.42391,{"lat":119,"lon":118},[122],{"name":123,"role":33,"phone":26,"phoneExt":26,"email":26},"Werner Albrich, Prof. Dr. med.",{"facility":125,"status":50,"city":126,"state":127,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":128,"geoPoint":132,"contacts":133},"Centre hospitalier universitaire vaudois (CHUV)","Lausanne","Canton of Vaud",{"type":56,"coordinates":129},[130,131],6.63282,46.516,{"lat":131,"lon":130},[134],{"name":135,"role":33,"phone":26,"phoneExt":26,"email":26},"Matthaios Papadimitriou-Olivgeris, PD Dr. med. PhD",{"facility":137,"status":50,"city":138,"state":139,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":140,"geoPoint":144,"contacts":145},"Kantonsspital Winterthur (KSW)","Winterthur","Canton of Zurich",{"type":56,"coordinates":141},[142,143],8.72413,47.50564,{"lat":143,"lon":142},[146],{"name":147,"role":33,"phone":26,"phoneExt":26,"email":26},"Urs Karrer, PD Dr. med.",{"facility":149,"status":50,"city":150,"state":139,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":151,"geoPoint":155,"contacts":156},"Stadtspital Zürich Triemli","Zurich",{"type":56,"coordinates":152},[153,154],8.55,47.36667,{"lat":154,"lon":153},[157],{"name":158,"role":33,"phone":26,"phoneExt":26,"email":26},"Adrian Schibli, Dr. med.",{"facility":160,"status":50,"city":150,"state":139,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":161,"geoPoint":163,"contacts":164},"Universitätsspital Zürich (USZ)",{"type":56,"coordinates":162},[153,154],{"lat":154,"lon":153},[165],{"name":166,"role":33,"phone":26,"phoneExt":26,"email":26},"Barbara Hasse, Prof. Dr. med.",{"facility":168,"status":50,"city":169,"state":170,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":171,"geoPoint":175,"contacts":176},"Ente Ospedaliero Cantonale (EOC)","Lugano","Canton Ticino",{"type":56,"coordinates":172},[173,174],8.96004,46.01008,{"lat":174,"lon":173},[177],{"name":178,"role":33,"phone":26,"phoneExt":26,"email":26},"Marco Bongiovanni, PD Dr. med.",{"facility":180,"status":50,"city":66,"state":26,"zip":181,"country":53,"countryCode":54,"cosmosGeoPoint":182,"geoPoint":184,"contacts":185},"University Hospital Basel (USB)","4031",{"type":56,"coordinates":183},[70,71],{"lat":71,"lon":70},[186,187],{"name":44,"role":40,"phone":45,"phoneExt":26,"email":46},{"name":32,"role":33,"phone":26,"phoneExt":26,"email":26},{"type":189,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[191],{"name":192,"class":6},"Swiss National Science Foundation","100054119","linezolid-plus-standard-of-care-100054119",false,"NCT06958835","Linezolid Plus Standard of Care","Combination Antibiotic Treatment With Linezolid for Staphylococcus Aureus Bacteraemia: a Randomised Controlled Trial","LIPS","Inclusion criteria:\n\n* Staphylococcus aureus (S. aureus) grown from at least one blood culture\n* Hospitalised at a participating centre\n* ≥18 years old\n* Written informed consent or fulfilling criteria for an emergency exception from informed consent requirements\n\nExclusion criteria:\n\n* Administration of the initial drug treatment not feasible within 72 hours since the collection of the first positive blood culture with S. aureus\n* Documented history of positive blood cultures for S. aureus occurring between 72 hours and 180 days prior to the eligibility assessment\n* Necrotising fasciitis\n* Currently receiving linezolid or clindamycin\n* Use of any monoamine oxidase A or B inhibitor within the last two weeks\n* Known hypersensitivity to linezolid or any other ingredients of the study drugs\n* Current severe thrombocytopenia (i.e. \\\u003C30 x 10\\^9\u002FL)\n* Application of study drug not possible (per mouth or per gastric tube)\n* Currently breastfeeding\n* Local treating team believes that death is imminent and inevitable\n* Patient is receiving end of life care and antibiotic treatment is not considered appropriate\n* Local treating team believes that participation in the study is not in the best interest of the patient\n* Any indication that the patient is unwilling to participate in the study including an advance directive stating such unwillingness","ALL","18 Years",{"count":204,"type":205},606,"ESTIMATED","INTERVENTIONAL",[208],"NA","The aim of the study is to assess whether targeting virulence factors by administering linezolid in addition to standard antibiotic treatment improves outcomes in patients with Staphylococcus aureus bacteraemia.",[211],"Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)",[213,9,214,215,216,217,218,219,220,221],"Virulence factors","Bloodstream Infection","Hierarchical composite endpoint","Staphylococcus aureus","Bacteremia","Bacteraemia","Methicillin-resistant Staphylococcus aureus (MRSA)","Penicillin-susceptible Staphylococcus aureus (PSSA)","Methicillin-susceptible Staphylococcus aureus (MSSA)","2026-07-09",{"date":224,"type":225},"2026-07-13","ACTUAL",{"date":227,"type":225},"2025-10-06",{"date":229,"type":205},"2028-10",{"name":5,"class":6},12]